AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

ImmuPharma PLC

3.25p -$2.95 (-47.58%)
LSE · 16 Sep 2026 08:02 UTC
Previous Close
3.21p
Day Range
3.23p3.5p
Year Range
3.23p16p
Market Cap
20.28M
AVG Volume
1.83M
Trailing/Forward PE
-3.19/-
PEG ratio
-0.09
Dividend Yield
-
Next Earnings Date
2026-09-24
Primary Exchange
London Stock ExchangeUK
Revenue (GBP)
-40K-30K-20K-10K023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Revenue (GBP) by quarter
PeriodRevenue (GBP)
25 Q40
25 Q30
25 Q20
25 Q10
24 Q40
24 Q30
24 Q20
24 Q10
23 Q4-34.98K
23 Q3-34.98K
Net Income (GBP)
-1.5M-1M-500K0500K23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Net Income (GBP) by quarter
PeriodNet Income (GBP)
25 Q431.21K
25 Q30
25 Q2-919.44K
25 Q1-919.44K
24 Q4-1.05M
24 Q3-1.05M
24 Q2-194K
24 Q1-194K
23 Q4-1.04M
23 Q3-1.04M
Operating Income (GBP)
-2M-1M01M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Operating Income (GBP) by quarter
PeriodOperating Income (GBP)
25 Q4-1.31M
25 Q3614.92K
25 Q2-1.24M
25 Q1-614.92K
24 Q4-1.52M
24 Q3-956K
24 Q2-764.23K
24 Q1-382K
23 Q4-882K
23 Q3-882K
EBITDA (GBP)
-1.5M-1M-500K023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L EBITDA (GBP) by quarter
PeriodEBITDA (GBP)
25 Q4-1.3M
25 Q3-648.77K
25 Q2-600.65K
25 Q1-600.65K
24 Q4-933K
24 Q3-933K
24 Q2-572.77K
24 Q1-373K
23 Q4-873K
23 Q3-866K
Cash Flows (GBP)
-1.5M-1M-500K023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Cash Flows (GBP) by quarter
PeriodCash Flows (GBP)
25 Q4-1.37M
25 Q3-684.45K
25 Q2-502.57K
25 Q1-502.57K
24 Q4-447.01K
24 Q3-447.01K
24 Q2-438.36K
24 Q1-438.36K
23 Q4-355.75K
23 Q3-355.75K
EPS (GBP)
-0-0-00023 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L EPS (GBP) by quarter
PeriodEPS (GBP)
25 Q40
25 Q30
25 Q2-0
25 Q1-0
24 Q4-0
24 Q3-0
24 Q2-0
24 Q1-0
23 Q4-0
23 Q3-0
Expenses (GBP)
0500K1M1.5MR&DSG&ACapex23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Expenses (GBP) by quarter
PeriodExpenses (GBP)
25 Q41.3M
25 Q3654.33K
25 Q2617.86K
25 Q1617.86K
24 Q4758.93K
24 Q3758.93K
24 Q2382.11K
24 Q1382.11K
23 Q4907.26K
23 Q3907.26K
Cash & Debt (GBP)
0500K1M1.5MCashLong Term DebtShort Term Debt23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Cash & Debt (GBP) by quarter
PeriodCash & Debt (GBP)
25 Q41.35M
25 Q31.35M
25 Q2396.65K
25 Q1396.65K
24 Q4236.9K
24 Q3236.9K
24 Q21.08M
24 Q11.08M
23 Q4208.48K
23 Q3208.48K
Debt ratios
00.20.40.623 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Debt ratios by quarter
PeriodDebt ratios
25 Q40.43
25 Q30.49
25 Q20.13
25 Q10.13
24 Q40.08
24 Q30.09
24 Q20.4
24 Q10.34
23 Q40.06
23 Q30.05
Margins
0%25%50%75%100%20 Q320 Q421 Q121 Q221 Q321 Q423 Q123 Q223 Q323 Q4
IMM.L Margins by quarter
PeriodMargins
23 Q4100%
23 Q3100%
23 Q215.97%
23 Q1100%
21 Q450%
21 Q3100%
21 Q250%
21 Q1100%
20 Q450%
20 Q3100%
Return on Capital
-400%-200%0%200%23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Return on Capital by quarter
PeriodReturn on Capital
25 Q44.54%
25 Q30%
25 Q2-273.07%
25 Q1-273.07%
24 Q4193.05%
24 Q3193.05%
24 Q2-7.21%
24 Q1-7.21%
23 Q4-98.17%
23 Q3-98.17%
Shares Outstanding
0200M400M600M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Shares Outstanding by quarter
PeriodShares Outstanding
25 Q4490.59M
25 Q3501.35M
25 Q2479.83M
25 Q1479.83M
24 Q4416.44M
24 Q3411.07M
24 Q2417.05M
24 Q1417.05M
23 Q4386.16M
23 Q3386.16M
Dividends (GBP)
00.511.52Dec 21
IMM.L Dividends (GBP) by quarter
PeriodDividends (GBP)
Dec 211
Book Value Per Share (GBP)
-00000.010.0123 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Book Value Per Share (GBP) by quarter
PeriodBook Value Per Share (GBP)
25 Q40
25 Q30
25 Q20
25 Q10
24 Q4-0
24 Q3-0
24 Q20.01
24 Q10.01
23 Q40
23 Q30
Total Assets (GBP)
02M4M6M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
IMM.L Total Assets (GBP) by quarter
PeriodTotal Assets (GBP)
25 Q41.88M
25 Q31.88M
25 Q21.58M
25 Q11.58M
24 Q4977.01K
24 Q3977.01K
24 Q24.06M
24 Q14.06M
23 Q42.72M
23 Q32.72M
ImmuPharma PLC
IMM.L
Stockpicker

Video analysis: IMM.L

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.